It says how long the unit lasts
The tirzepatide page prints a one-time price beside a stated duration of roughly three months. That is a complete price statement: a figure, a unit and a period. Very little on this roster manages all three, and a good deal of it manages the first while implying the third.
This review records it exactly that way, without a per-month suffix. Dividing the figure by three would produce a number the seller never stated and would put a monthly-looking price into a comparison where it does not belong.
A quarter of medication, sold like a product
The commercial model here is a shop, not a programme. A patient buys a unit, receives delivery materials and instructions, and that is the transaction. There is no subscription, nothing to cancel, and nothing described about what happens between purchases.
That suits a reader who knows what they are doing and wants a quarter of medication without a monthly relationship. It suits nobody starting treatment for the first time, because the site documents no titration review and no route to a clinician between orders.
The dose range is wide and the price is fixed
The product page gives a dose range spanning a threefold difference and attaches one price to all of it. That means the stated three-month duration depends on a dose the page does not fix, and a patient at the top of the range will exhaust the unit considerably sooner than one at the bottom.
So the duration is honest as a statement and soft as a planning number. It is still better than the alternative, which is a monthly suffix on a figure whose period nobody has established.
There is no second molecule
Tirzepatide is the only GLP-1 in a catalogue otherwise built from recovery stacks, cognitive compounds, longevity peptides and hormone products. A patient who does not tolerate it has nowhere to go inside this seller.
No compounding pharmacy is named beyond a licensing class. No list of states served appears anywhere we read. No prescribing clinician or medical director is identified, and nothing states whether a membership applies.
Bowery Clinic's published pricing
| Medication | Price | Verified |
|---|---|---|
| Tirzepatide (compounded) | $699one-time price for the single unit the product page says lasts approximately 3 months; no monthly rate is offered and none is implied | September 2026source |
compareglp may earn a commission when a reader signs up with a provider through a link on this site. 4 of the 283 providers reviewed here are paid partners today; the other 279 are not. See how this works.
See Bowery Clinic's current price →Good fit if
- Readers who want a quarter of tirzepatide at a stated one-time price with the duration printed.
- Patients who prefer buying a product to enrolling in a subscription.
- Anyone already familiar with their own dose who does not need titration support.
- Readers browsing a broad peptide catalogue where every stack names its constituents.
Look elsewhere if
- Anyone starting GLP-1 treatment for the first time; nothing here documents supervision or titration review.
- Patients who want semaglutide, which this seller does not offer.
- Readers comparing monthly costs, since this is a one-time price covering roughly a quarter.
- Anyone who needs the compounding pharmacy named or the state footprint published.
How this review was verified
- Read the tirzepatide product page and the catalogue homepage at their source URLs and logged the figure with the date it was read.
- Took the approximate three-month duration from the product page itself and recorded the figure without a per-month suffix on that basis.
- Checked whether a semaglutide product exists anywhere in the catalogue; it does not.
- Recorded the pharmacy, prescriber, state and membership positions as gaps rather than inferring any of them.
- Pulled all 3,677 rows of the FDA warning-letter table and filtered them locally with a known-positive and a nonsense-string control in the same run; no letter found.